Status:
RECRUITING
Impact of a Multidisciplinary Assessment in Day Hospitalization Versus Standard Care on the Deployment of Supportive Oncology Care Recommended by the Personalized Post-cancer Plan in Patients at the End of Initial Treatment for Gynecological Ovarian and Endometrial Cancer Endometrial Cancer
Lead Sponsor:
Centre Francois Baclesse
Conditions:
Gynecologic Cancer
Remission
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
This project proposes a structuring of supportive oncology care for the recovery phase after gynecological cancer (ovarian/trope/peritoneum or endometrium). Patients will be divided into three groups ...
Eligibility Criteria
Inclusion
- Patient \> 18 years
- Patients in remission from first-line treatment of endometrial or ovarian/tumor/peritoneal cancer.
- Patient who has completed her initial treatment; patients on maintenance therapy are eligible.
- Fluency in French
- Patient with access to a telephone line
- Patient affiliated to a social security scheme
- Signature of informed consent prior to any specific study procedure
Exclusion
- Any associated medical or psychiatric condition that could compromise the patient's ability to participate in the study
- Patient with locoregional or metastatic recurrence
- Patient deprived of liberty, under guardianship or curatorship
- Simultaneous participation in a therapeutic clinical trial
Key Trial Info
Start Date :
June 7 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 7 2028
Estimated Enrollment :
268 Patients enrolled
Trial Details
Trial ID
NCT06553612
Start Date
June 7 2024
End Date
June 7 2028
Last Update
January 8 2026
Active Locations (13)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU, Besançon
Besançon, France
2
François Baclesse
Caen, France
3
Centre Jean Perrin
Clermont-Ferrand, France
4
Centre Léon Bérard
Lyon, France